{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:39:48Z","timestamp":1784302788401,"version":"3.55.0"},"reference-count":63,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/14737175.2021.1979959","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T17:07:00Z","timestamp":1631552820000},"page":"1059-1068","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients"],"prefix":"10.1080","volume":"21","author":[{"given":"Wolfgang H.","family":"Jost","sequence":"first","affiliation":[{"name":"Parkinson-Klinik Ortenau, Wolfach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Steffen","sequence":"additional","affiliation":[{"name":"Department for Otorhinolaryngology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Berweck","sequence":"additional","affiliation":[{"name":"Specialist Center for Paediatric Neurology, Neurorehabilitation and Epileptology, Sch\u00f6n Klinik, Vogtareuth, Germany"},{"name":"Department of Pediatric Neurology and Developmental Medicine, LMU Center for Children with Medical Complexity - Integrated Social Pediatric Center, Dr. Von Hauner Children\u2019s Hospital, Ludwig Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-019-00155-6"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.3390\/toxins5051010"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2016.03.006"},{"issue":"820","key":"cit0004","first-page":"825","volume":"68","author":"Crysdale WS","year":"1989","journal-title":"Ear Nose Throat J"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1992.tb11382.x"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.infbeh.2018.01.004"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.240"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.14391"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1855146"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02000-4"},{"key":"cit0011","first-page":"2628","volume":"69","author":"Hockstein NG","year":"2004","journal-title":"Am Fam Physician"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S39253"},{"key":"cit0013","unstructured":"Glader L, Delsing C, Hughes A, et al. Sialorrhea in cerebral palsy. 2018. Available at: https:\/\/www.aacpdm.org\/publications\/care-pathways\/sialorrhea[Lastaccessed03May2021]"},{"key":"cit0014","unstructured":"National Institute for Health and Care Excellence. Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide. Evidence summary. 2017 Feb 14. [cited 2021 May 17]. Available at: https:\/\/www.nice.org.uk\/advice\/es5\/chapter\/Introduction-and-current-guidance."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-014-0077-1"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-015-1416-2"},{"key":"cit0017","unstructured":"Solstice Neurosciences LLC. MYOBLOC\u00ae (rimabotulinumtoxinB) injection, for intramuscular or intraglandular use. 2000. Prescribing information. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/103846s5190lbl.pdf[Lastaccessed17May2021]"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199911)14:6<1057::AID-MDS1033>3.0.CO;2-4"},{"key":"cit0019","doi-asserted-by":"crossref","first-page":"e1195","DOI":"10.1212\/WNL.0000000000007081","volume":"92","author":"Bekkers S","year":"2019","journal-title":"Neurology"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2015.09.014"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12881"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1177\/0194599812465059"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007368"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.11.024"},{"key":"cit0025","volume-title":"Neurology","author":"Berweck S","year":"2021"},{"key":"cit0026","first-page":"16","volume-title":"Poster presented at TOXINS 2021 Virtual Conference","author":"Berweck S","year":"2021"},{"key":"cit0027","first-page":"16","volume-title":"Poster presented at TOXINS 2021 Virtual Conference","author":"Berweck S","year":"2021"},{"key":"cit0028","unstructured":"Merz Pharmaceutical, LLC. XEOMIN- incobotulinumtoxina injection, powder, lyophilized, for solution. 2020. Prescribing information. Available at: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=ccdc3aae-6e2d-4cd0-a51c-8375bfee9458&type=display[Lastaccessed26April2021]"},{"key":"cit0029","unstructured":"Merz Pharma UK Ltd. Xeomin 100 units powder for solution for injection. Summary of prescribing information. 2020. [cited 2021 Apr 26]. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/6202\/smpc"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S79193"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1177\/1090820X12474633"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.11138\/FNeur\/2018.33.1.007"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00089-18"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-4257(01)00086-9"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09681-7"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009444"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006688"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767050-00003"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(02)00381-8"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200201000-00014"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-37084"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1097\/01.PHM.0000104680.28335.B9"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206001939"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215107006949"},{"key":"cit0045","first-page":"141","volume":"7","author":"Ong LC","year":"2009","journal-title":"J Pediatr Neurol"},{"issue":"120","key":"cit0046","volume":"20","author":"Hassin-Baer S","year":"2005","journal-title":"J Child Neurol"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000142040.57474.A6"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-1104-L"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000300421.38081.7d"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1111\/j.0012-1622.2008.02010.x"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.09.001"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7072481"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1112115"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1307457"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2019.04.001"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1177\/0883073810395391"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.147"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.02.011"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2011.06.002"},{"key":"cit0060","unstructured":"Proveca Limited. Sialanar 320 micrograms\/ml Glycopyrronium (400 micrograms\/ml Glycopyrronium Bromide) Oral Solution. Summary of prescribing information. 2020. [cited 2021 May 19]. Available at: https:\/\/www.medicines.org.uk\/emc\/medicine\/32715]"},{"key":"cit0061","unstructured":"Merz Pharmaceutical LLC. CUVPOSA (glycopyrrolate) oral solution. 2018. Prescribing information. [cited 2021 May 27]. Available at: https:\/\/www.cuvposa.com\/wp-content\/themes\/cuvposa\/assets\/cuvposa-prescribing-information.pdf."},{"key":"cit0062","first-page":"16","volume-title":"Poster presented at TOXINS 2021 Virtual Conference","author":"Berweck S","year":"2021"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2020.11.353"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2021.1979959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T02:55:22Z","timestamp":1673232922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2021.1979959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,3]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/14737175.2021.1979959"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2021.1979959","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}